OTLERTUZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 08:40:03 GMT 2023` Edited by `admin` on `Sat Dec 16 08:40:03 GMT 2023`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	2MZ3L2664T
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

OTLERTUZUMAB

Official Name

English

OTLERTUZUMAB [USAN]

Common Name

English

TRU-016

Code

English

otlertuzumab [INN]

Common Name

English

Otlertuzumab [WHO-DD]

Common Name

English

IMMUNOGLOBULIN, ANTI-(HUMAN CD ANTIGEN CD37) (SYNTHETIC HUMAN-MUS MUSCULUS FRAGMENT TRU-016), DIMER

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

353411

Created by admin on Sat Dec 16 08:40:03 GMT 2023 , Edited by admin on Sat Dec 16 08:40:03 GMT 2023

NCI_THESAURUS

C2139

Created by admin on Sat Dec 16 08:40:03 GMT 2023 , Edited by admin on Sat Dec 16 08:40:03 GMT 2023

Code System Code Type Description

NCI_THESAURUS

C74006

Created by admin on Sat Dec 16 08:40:03 GMT 2023 , Edited by admin on Sat Dec 16 08:40:03 GMT 2023

PRIMARY

INN

9832

Created by admin on Sat Dec 16 08:40:03 GMT 2023 , Edited by admin on Sat Dec 16 08:40:03 GMT 2023

PRIMARY

CAS

1372645-37-8

Created by admin on Sat Dec 16 08:40:03 GMT 2023 , Edited by admin on Sat Dec 16 08:40:03 GMT 2023

PRIMARY

ChEMBL

CHEMBL3039539

Created by admin on Sat Dec 16 08:40:03 GMT 2023 , Edited by admin on Sat Dec 16 08:40:03 GMT 2023

PRIMARY

WIKIPEDIA

Otlertuzumab

Created by admin on Sat Dec 16 08:40:03 GMT 2023 , Edited by admin on Sat Dec 16 08:40:03 GMT 2023

PRIMARY

FDA UNII

2MZ3L2664T

Created by admin on Sat Dec 16 08:40:03 GMT 2023 , Edited by admin on Sat Dec 16 08:40:03 GMT 2023

PRIMARY

USAN

ZZ-172

Created by admin on Sat Dec 16 08:40:03 GMT 2023 , Edited by admin on Sat Dec 16 08:40:03 GMT 2023

PRIMARY

EVMPD

SUB181347

Created by admin on Sat Dec 16 08:40:03 GMT 2023 , Edited by admin on Sat Dec 16 08:40:03 GMT 2023

PRIMARY

From	To
1_22	1_96
1_164	1_229
1_265	2_265
1_297	1_357
1_403	1_461
2_22	2_96
2_164	2_229
2_297	2_357
2_403	2_461

Glycosylation Link Type	Site
N	1_333
N	2_333

Related Record Type Details


					VTD13G7FDK

LEUKOCYTE ANTIGEN CD37

TARGET -> INHIBITOR

Related Record Type Details


					2MZ3L2664T

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL